Global Cancer Molecular Biomarkers Market Insights and Forecast to 2031

Report ID: 1665268 | Published Date: Dec 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Molecular Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Genetic Methods
        1.2.3 Protein Methods
        1.2.4 Imaging
    1.3 Market by Application
        1.3.1 Global Cancer Molecular Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pharmaceutical
        1.3.3 Medical Laboratory
        1.3.4 Hospital
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Molecular Biomarkers Market Perspective (2017-2028)
    2.2 Cancer Molecular Biomarkers Growth Trends by Region
        2.2.1 Cancer Molecular Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Molecular Biomarkers Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Molecular Biomarkers Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Molecular Biomarkers Market Dynamics
        2.3.1 Cancer Molecular Biomarkers Industry Trends
        2.3.2 Cancer Molecular Biomarkers Market Drivers
        2.3.3 Cancer Molecular Biomarkers Market Challenges
        2.3.4 Cancer Molecular Biomarkers Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Molecular Biomarkers Players by Revenue
        3.1.1 Global Top Cancer Molecular Biomarkers Players by Revenue (2017-2022)
        3.1.2 Global Cancer Molecular Biomarkers Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Molecular Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Molecular Biomarkers Revenue
    3.4 Global Cancer Molecular Biomarkers Market Concentration Ratio
        3.4.1 Global Cancer Molecular Biomarkers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Molecular Biomarkers Revenue in 2021
    3.5 Cancer Molecular Biomarkers Key Players Head office and Area Served
    3.6 Key Players Cancer Molecular Biomarkers Product Solution and Service
    3.7 Date of Enter into Cancer Molecular Biomarkers Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Molecular Biomarkers Breakdown Data by Type
    4.1 Global Cancer Molecular Biomarkers Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2023-2028)
5 Cancer Molecular Biomarkers Breakdown Data by Application
    5.1 Global Cancer Molecular Biomarkers Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Molecular Biomarkers Market Size (2017-2028)
    6.2 North America Cancer Molecular Biomarkers Market Size by Type
        6.2.1 North America Cancer Molecular Biomarkers Market Size by Type (2017-2022)
        6.2.2 North America Cancer Molecular Biomarkers Market Size by Type (2023-2028)
        6.2.3 North America Cancer Molecular Biomarkers Market Share by Type (2017-2028)
    6.3 North America Cancer Molecular Biomarkers Market Size by Application
        6.3.1 North America Cancer Molecular Biomarkers Market Size by Application (2017-2022)
        6.3.2 North America Cancer Molecular Biomarkers Market Size by Application (2023-2028)
        6.3.3 North America Cancer Molecular Biomarkers Market Share by Application (2017-2028)
    6.4 North America Cancer Molecular Biomarkers Market Size by Country
        6.4.1 North America Cancer Molecular Biomarkers Market Size by Country (2017-2022)
        6.4.2 North America Cancer Molecular Biomarkers Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cancer Molecular Biomarkers Market Size (2017-2028)
    7.2 Europe Cancer Molecular Biomarkers Market Size by Type
        7.2.1 Europe Cancer Molecular Biomarkers Market Size by Type (2017-2022)
        7.2.2 Europe Cancer Molecular Biomarkers Market Size by Type (2023-2028)
        7.2.3 Europe Cancer Molecular Biomarkers Market Share by Type (2017-2028)
    7.3 Europe Cancer Molecular Biomarkers Market Size by Application
        7.3.1 Europe Cancer Molecular Biomarkers Market Size by Application (2017-2022)
        7.3.2 Europe Cancer Molecular Biomarkers Market Size by Application (2023-2028)
        7.3.3 Europe Cancer Molecular Biomarkers Market Share by Application (2017-2028)
    7.4 Europe Cancer Molecular Biomarkers Market Size by Country
        7.4.1 Europe Cancer Molecular Biomarkers Market Size by Country (2017-2022)
        7.4.2 Europe Cancer Molecular Biomarkers Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Molecular Biomarkers Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type
        8.2.1 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cancer Molecular Biomarkers Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application
        8.3.1 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cancer Molecular Biomarkers Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region
        8.4.1 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cancer Molecular Biomarkers Market Size (2017-2028)
    9.2 Latin America Cancer Molecular Biomarkers Market Size by Type
        9.2.1 Latin America Cancer Molecular Biomarkers Market Size by Type (2017-2022)
        9.2.2 Latin America Cancer Molecular Biomarkers Market Size by Type (2023-2028)
        9.2.3 Latin America Cancer Molecular Biomarkers Market Share by Type (2017-2028)
    9.3 Latin America Cancer Molecular Biomarkers Market Size by Application
        9.3.1 Latin America Cancer Molecular Biomarkers Market Size by Application (2017-2022)
        9.3.2 Latin America Cancer Molecular Biomarkers Market Size by Application (2023-2028)
        9.3.3 Latin America Cancer Molecular Biomarkers Market Share by Application (2017-2028)
    9.4 Latin America Cancer Molecular Biomarkers Market Size by Country
        9.4.1 Latin America Cancer Molecular Biomarkers Market Size by Country (2017-2022)
        9.4.2 Latin America Cancer Molecular Biomarkers Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Molecular Biomarkers Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type
        10.2.1 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cancer Molecular Biomarkers Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application
        10.3.1 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cancer Molecular Biomarkers Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country
        10.4.1 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Correlogic Systems
        11.1.1 Correlogic Systems Company Details
        11.1.2 Correlogic Systems Business Overview
        11.1.3 Correlogic Systems Cancer Molecular Biomarkers Introduction
        11.1.4 Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.1.5 Correlogic Systems Recent Developments
    11.2 AgendiaBv
        11.2.1 AgendiaBv Company Details
        11.2.2 AgendiaBv Business Overview
        11.2.3 AgendiaBv Cancer Molecular Biomarkers Introduction
        11.2.4 AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.2.5 AgendiaBv Recent Developments
    11.3 BioMerieux
        11.3.1 BioMerieux Company Details
        11.3.2 BioMerieux Business Overview
        11.3.3 BioMerieux Cancer Molecular Biomarkers Introduction
        11.3.4 BioMerieux Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.3.5 BioMerieux Recent Developments
    11.4 Aureon Laboratories
        11.4.1 Aureon Laboratories Company Details
        11.4.2 Aureon Laboratories Business Overview
        11.4.3 Aureon Laboratories Cancer Molecular Biomarkers Introduction
        11.4.4 Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.4.5 Aureon Laboratories Recent Developments
    11.5 Astellas Pharma US
        11.5.1 Astellas Pharma US Company Details
        11.5.2 Astellas Pharma US Business Overview
        11.5.3 Astellas Pharma US Cancer Molecular Biomarkers Introduction
        11.5.4 Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.5.5 Astellas Pharma US Recent Developments
    11.6 Becton
        11.6.1 Becton Company Details
        11.6.2 Becton Business Overview
        11.6.3 Becton Cancer Molecular Biomarkers Introduction
        11.6.4 Becton Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.6.5 Becton Recent Developments
    11.7 Diadexus
        11.7.1 Diadexus Company Details
        11.7.2 Diadexus Business Overview
        11.7.3 Diadexus Cancer Molecular Biomarkers Introduction
        11.7.4 Diadexus Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.7.5 Diadexus Recent Developments
    11.8 Abbott Laboratories
        11.8.1 Abbott Laboratories Company Details
        11.8.2 Abbott Laboratories Business Overview
        11.8.3 Abbott Laboratories Cancer Molecular Biomarkers Introduction
        11.8.4 Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.8.5 Abbott Laboratories Recent Developments
    11.9 Affymetrix
        11.9.1 Affymetrix Company Details
        11.9.2 Affymetrix Business Overview
        11.9.3 Affymetrix Cancer Molecular Biomarkers Introduction
        11.9.4 Affymetrix Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.9.5 Affymetrix Recent Developments
    11.10 Clarient
        11.10.1 Clarient Company Details
        11.10.2 Clarient Business Overview
        11.10.3 Clarient Cancer Molecular Biomarkers Introduction
        11.10.4 Clarient Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.10.5 Clarient Recent Developments
    11.11 Biomoda
        11.11.1 Biomoda Company Details
        11.11.2 Biomoda Business Overview
        11.11.3 Biomoda Cancer Molecular Biomarkers Introduction
        11.11.4 Biomoda Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.11.5 Biomoda Recent Developments
    11.12 Beckman Coulter
        11.12.1 Beckman Coulter Company Details
        11.12.2 Beckman Coulter Business Overview
        11.12.3 Beckman Coulter Cancer Molecular Biomarkers Introduction
        11.12.4 Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.12.5 Beckman Coulter Recent Developments
    11.13 Dickinson
        11.13.1 Dickinson Company Details
        11.13.2 Dickinson Business Overview
        11.13.3 Dickinson Cancer Molecular Biomarkers Introduction
        11.13.4 Dickinson Revenue in Cancer Molecular Biomarkers Business (2017-2022)
        11.13.5 Dickinson Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Cancer Molecular Biomarkers Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Genetic Methods
    Table 3. Key Players of Protein Methods
    Table 4. Key Players of Imaging
    Table 5. Global Cancer Molecular Biomarkers Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Cancer Molecular Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Cancer Molecular Biomarkers Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Cancer Molecular Biomarkers Market Share by Region (2017-2022)
    Table 9. Global Cancer Molecular Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Cancer Molecular Biomarkers Market Share by Region (2023-2028)
    Table 11. Cancer Molecular Biomarkers Market Trends
    Table 12. Cancer Molecular Biomarkers Market Drivers
    Table 13. Cancer Molecular Biomarkers Market Challenges
    Table 14. Cancer Molecular Biomarkers Market Restraints
    Table 15. Global Cancer Molecular Biomarkers Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Cancer Molecular Biomarkers Revenue Share by Players (2017-2022)
    Table 17. Global Top Cancer Molecular Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Molecular Biomarkers as of 2021)
    Table 18. Ranking of Global Top Cancer Molecular Biomarkers Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Cancer Molecular Biomarkers Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cancer Molecular Biomarkers Product Solution and Service
    Table 22. Date of Enter into Cancer Molecular Biomarkers Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cancer Molecular Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2017-2022)
    Table 26. Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2023-2028)
    Table 28. Global Cancer Molecular Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Cancer Molecular Biomarkers Revenue Share by Application (2017-2022)
    Table 30. Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Cancer Molecular Biomarkers Revenue Share by Application (2023-2028)
    Table 32. North America Cancer Molecular Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Cancer Molecular Biomarkers Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Cancer Molecular Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Cancer Molecular Biomarkers Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Cancer Molecular Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Cancer Molecular Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Cancer Molecular Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Cancer Molecular Biomarkers Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Cancer Molecular Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Cancer Molecular Biomarkers Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Cancer Molecular Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Cancer Molecular Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Cancer Molecular Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Cancer Molecular Biomarkers Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Cancer Molecular Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Cancer Molecular Biomarkers Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Cancer Molecular Biomarkers Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Cancer Molecular Biomarkers Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Cancer Molecular Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Cancer Molecular Biomarkers Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Cancer Molecular Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Cancer Molecular Biomarkers Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Cancer Molecular Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Cancer Molecular Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Cancer Molecular Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Cancer Molecular Biomarkers Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Cancer Molecular Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Cancer Molecular Biomarkers Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Cancer Molecular Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Cancer Molecular Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Correlogic Systems Company Details
    Table 63. Correlogic Systems Business Overview
    Table 64. Correlogic Systems Cancer Molecular Biomarkers Product
    Table 65. Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 66. Correlogic Systems Recent Developments
    Table 67. AgendiaBv Company Details
    Table 68. AgendiaBv Business Overview
    Table 69. AgendiaBv Cancer Molecular Biomarkers Product
    Table 70. AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 71. AgendiaBv Recent Developments
    Table 72. BioMerieux Company Details
    Table 73. BioMerieux Business Overview
    Table 74. BioMerieux Cancer Molecular Biomarkers Product
    Table 75. BioMerieux Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 76. BioMerieux Recent Developments
    Table 77. Aureon Laboratories Company Details
    Table 78. Aureon Laboratories Business Overview
    Table 79. Aureon Laboratories Cancer Molecular Biomarkers Product
    Table 80. Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 81. Aureon Laboratories Recent Developments
    Table 82. Astellas Pharma US Company Details
    Table 83. Astellas Pharma US Business Overview
    Table 84. Astellas Pharma US Cancer Molecular Biomarkers Product
    Table 85. Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 86. Astellas Pharma US Recent Developments
    Table 87. Becton Company Details
    Table 88. Becton Business Overview
    Table 89. Becton Cancer Molecular Biomarkers Product
    Table 90. Becton Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 91. Becton Recent Developments
    Table 92. Diadexus Company Details
    Table 93. Diadexus Business Overview
    Table 94. Diadexus Cancer Molecular Biomarkers Product
    Table 95. Diadexus Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 96. Diadexus Recent Developments
    Table 97. Abbott Laboratories Company Details
    Table 98. Abbott Laboratories Business Overview
    Table 99. Abbott Laboratories Cancer Molecular Biomarkers Product
    Table 100. Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 101. Abbott Laboratories Recent Developments
    Table 102. Affymetrix Company Details
    Table 103. Affymetrix Business Overview
    Table 104. Affymetrix Cancer Molecular Biomarkers Product
    Table 105. Affymetrix Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 106. Affymetrix Recent Developments
    Table 107. Clarient Company Details
    Table 108. Clarient Business Overview
    Table 109. Clarient Cancer Molecular Biomarkers Product
    Table 110. Clarient Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 111. Clarient Recent Developments
    Table 112. Biomoda Company Details
    Table 113. Biomoda Business Overview
    Table 114. Biomoda Cancer Molecular Biomarkers Product
    Table 115. Biomoda Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 116. Biomoda Recent Developments
    Table 117. Beckman Coulter Company Details
    Table 118. Beckman Coulter Business Overview
    Table 119. Beckman Coulter Cancer Molecular Biomarkers Product
    Table 120. Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 121. Beckman Coulter Recent Developments
    Table 122. Dickinson Company Details
    Table 123. Dickinson Business Overview
    Table 124. Dickinson Cancer Molecular Biomarkers Product
    Table 125. Dickinson Revenue in Cancer Molecular Biomarkers Business (2017-2022) & (US$ Million)
    Table 126. Dickinson Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Molecular Biomarkers Market Share by Type: 2021 VS 2028
    Figure 2. Genetic Methods Features
    Figure 3. Protein Methods Features
    Figure 4. Imaging Features
    Figure 5. Global Cancer Molecular Biomarkers Market Share by Application: 2021 VS 2028
    Figure 6. Pharmaceutical Case Studies
    Figure 7. Medical Laboratory Case Studies
    Figure 8. Hospital Case Studies
    Figure 9. Cancer Molecular Biomarkers Report Years Considered
    Figure 10. Global Cancer Molecular Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Cancer Molecular Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cancer Molecular Biomarkers Market Share by Region: 2021 VS 2028
    Figure 13. Global Cancer Molecular Biomarkers Market Share by Players in 2021
    Figure 14. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Molecular Biomarkers as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Cancer Molecular Biomarkers Revenue in 2021
    Figure 16. North America Cancer Molecular Biomarkers Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Cancer Molecular Biomarkers Market Size Market Share by Type (2017-2028)
    Figure 18. North America Cancer Molecular Biomarkers Market Size Market Share by Application (2017-2028)
    Figure 19. North America Cancer Molecular Biomarkers Market Size Share by Country (2017-2028)
    Figure 20. United States Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Cancer Molecular Biomarkers Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Cancer Molecular Biomarkers Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Cancer Molecular Biomarkers Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Cancer Molecular Biomarkers Market Size Share by Country (2017-2028)
    Figure 26. Germany Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cancer Molecular Biomarkers Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Cancer Molecular Biomarkers Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Cancer Molecular Biomarkers Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Cancer Molecular Biomarkers Market Size Share by Region (2017-2028)
    Figure 36. China Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Cancer Molecular Biomarkers Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Cancer Molecular Biomarkers Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Cancer Molecular Biomarkers Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Cancer Molecular Biomarkers Market Size Share by Country (2017-2028)
    Figure 46. Mexico Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Cancer Molecular Biomarkers Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Cancer Molecular Biomarkers Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Cancer Molecular Biomarkers Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Cancer Molecular Biomarkers Market Size Share by Country (2017-2028)
    Figure 52. Turkey Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Cancer Molecular Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Correlogic Systems Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 56. AgendiaBv Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 57. BioMerieux Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 58. Aureon Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 59. Astellas Pharma US Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 60. Becton Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 61. Diadexus Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 62. Abbott Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 63. Affymetrix Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 64. Clarient Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 65. Biomoda Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 66. Beckman Coulter Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 67. Dickinson Revenue Growth Rate in Cancer Molecular Biomarkers Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Clarient
Biomoda
Beckman Coulter
Dickinson
Frequently Asked Questions
Cancer Molecular Biomarkers report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Molecular Biomarkers report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Molecular Biomarkers report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cantaloupe

Cantaloupe market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More

Caprylic Alcohol

Caprylic Alcohol market is segmented by Type and by Application. Players, stakeholders, and other ... Read More